Navigation Links
InterMune Reports Preliminary Fourth Quarter 2011 Esbriet® (pirfenidone) Revenue and Other Recent Business Highlights
Date:1/5/2012

d range announced during InterMune's Third Quarter 2011 earnings call of $160 to $180 million.

Guidance for 2012 Expenses

The company provided its forward-looking financial guidance for operating expenses in 2012:

  • R&D expense: currently anticipated to be in a range of $95 to $115 million
  • SG&A expense: currently anticipated to be in a range of $120 to $145 million. 
  • Total Operating Expenses (R&D and SG&A): currently anticipated to be in a range of $215 to $260 million.


Conference Call and Webcast Details

InterMune will host a live webcast of a conference call today at 8:30 a.m. EST to discuss the Esbriet launch in Germany, the plans to launch Esbriet in other countries in the EU, the RECAP data and its updated operating expense guidance for 2011 and forward-looking operating expense guidance for 2012.  Interested investors and others may participate in the conference call by dialing 888-567-5125 (U.S.) or 706-643-9223 (international), conference ID# 40200495.  A replay of the webcast and teleconference will be available approximately three hours after the call.

To access the webcast, please log on to the company's website at www.intermune.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

A telephonic replay will be available for 10 business days following the call and can be accessed by dialing 855-859-2056 (U.S.) or 404-537-3406 (international), and entering the conference ID# 40200495.   

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and fibrotic diseases.  In pulmonology, we are focused on
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. InterMune Appoints Angus C. Russell to Board of Directors
2. InterMune to Release Third Quarter Financial Results on November 3
3. InterMune Announces Launch of Esbriet® (pirfenidone) in Germany
4. InterMune to Provide Overview of Corporate Strategy, Update on Esbriet Commercialization Plans in the EU and Details of Phase 3 ASCEND Study
5. InterMune Receives European Union Approval for Esbriet® (pirfenidone)
6. InterMune Reports Fourth Quarter and Full Year 2010 Financial Results and Business Highlights
7. InterMune to Present at J.P. Morgan Healthcare Conference
8. InterMune Reports Third Quarter 2010 Financial Results
9. InterMune Announces Four Oral Presentations on Pirfenidone and IPF at the Annual Congress of the European Respiratory Society (ERS)
10. InterMune to Release Second Quarter Financial Results on July 27
11. InterMune Announces Conference Call and Webcast to Discuss Outcome of FDA Advisory Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... 2013 Medical devices are any medical items ... In light of their different mechanisms, actions and regulatory ... complicated than drug trails due to their unique clinical ... of evaluating both safety and efficacy (which is left ... the same as the SFDA) evaluate MDs for both ...
(Date:5/17/2013)...  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) ... Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from ... (NIAID), a division of the National Institutes of ... antibody therapeutics to combat Staphylococcus aureus ... methicillin-resistant S. aureus (MRSA), was renewed ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
... indicates that anti-inflammatory drugs may become a new tool ... leading global cause of death. In investigating a specific ... researchers used the Cardiochip, a gene analysis tool designed ... Center for Applied Genomics at The Children,s Hospital of ...
... March 14, 2012 OncoSec Medical Incorporated ... Medical System (OMS) ElectroOncology therapies to treat solid ... Institute in Santa Monica, CA, and Lakeland Comprehensive ... as enrolling sites, and investigators are screening patients ...
Cached Medicine Technology:Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 2Gene Chip, Invented by Children's Hospital of Philadelphia Scientist, Pinpoints New Target to Prevent Heart Disease 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4
(Date:5/19/2013)... The muscles in the human body ... one of the biggest and most significant nervous systems ... peripheral system comprises of peripheral nerves that reside outside ... ensure that the limbs and hands, as well as ... get damaged due to trauma or physical injury, their ...
(Date:5/19/2013)... 2013 Grinding your teeth at night ... or annoying your spouse. At the same time, according ... (“Snoring and Teeth Grinding Could Be a Sign of ... can be hard to prevent. Apparently, Obstructive Sleep Disorder ... of its symptoms is a habit of teeth grinding ...
(Date:5/19/2013)... TX (PRWEB) May 19, 2013 6Webs.com ... systems companies. Homeowners who are considering an alarm ... services of the nation's leading security system providers online ... reviews the best DIY home security system ... year 6Webs.com reviews dozens of home security companies before ...
(Date:5/19/2013)... The report “Feed Additives Market by Types, Livestock ... 2017” published by MarketsandMarkets, defines and segments the global ... the global volume and revenue for the animal feed ... for the global market with analysis of trends, opportunities, ... segmented and revenue is forecasted on the basis of ...
(Date:5/19/2013)... 2013 The Pradaxa lawyers at Bernstein ... recently convened for hundreds of Pradaxa bleeding ... in U.S. District Court, Southern District of Illinois. ... May 14th, the Conference addressed the status of depositions ... the Conference that Defendants submitted a list of early ...
Breaking Medicine News(10 mins):Health News:Ultimate Neuropathy Support System Launched by Neuracel - Reaching New Heights in Herbal Medication for Peripheral Neuropathy 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Top Rated DIY Home Security System Companies Published by 6Webs.com 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 2Health News:Feed Additives Market to Reach $19.5 Billion by 2017 at a CAGR of 3.8% - New Report by MarketandMarkets 3Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... Order Halting July 1st Wage Cut , , OAKLAND, ... Thursday evening upon hearing the news that a U.S. District Court ... a proposed $2 an hour cut in wages for the state,s ... pay cuts in all California counties that were planning on passing ...
... for former GM and Delphi workers in restructuring , ... Ohio congressional members and U.S. Sen. Sherrod Brown (D-OH) to ... today, urging ,simple justice, with equity in financial support for ... represented by the United Steelworkers (USW) and two other unions. ...
... Rayner, executive director of the New Jersey Lawsuit Reform ... organizations dedicated to improving the state,s civil justice system ... in the courts, today issued the following statement in ... discontinue Accutane(R), a treatment for severe acne: , ...
... red meat and dairy products, study finds, , FRIDAY, ... and dairy products can increase your risk for pancreatic ... , Pancreatic cancer, which is usually fatal, is the ... Various risk factors for developing the disease have been ...
... Corporation, the company that will become public from the planned ... announced that Robert Friel will serve on the company,s board ... , Friel, 53, is chairman and chief executive officer of ... and safety of people and the environment. He joined PerkinElmer ...
... firing led to doctor,s claims of slander, breach of contract , ... an $8.6 million judgment against his employer two years ago won ... favor. , , The Court of Appeals for ... favor of Dr. Neal Fisher following a 2007 judgment against Pinnacle ...
Cached Medicine News:Health News:Judge Rules on SEIU Lawsuit 2Health News:Ohio Congressional Members Urge U.S. to Provide GM Retirees Medical Benefits 2Health News:Ohio Congressional Members Urge U.S. to Provide GM Retirees Medical Benefits 3Health News:Eating Animal Fat May Lead to Pancreatic Cancer 2Health News:Eating Animal Fat May Lead to Pancreatic Cancer 3Health News:CareFusion Names Robert Friel to Board of Directors 2Health News:CareFusion Names Robert Friel to Board of Directors 3Health News:Appeals Court OKs Multimillion-Dollar Judgment for Dallas Doctor 2
... is ideal as a primary chemistry-immuno ... and laboratories or as a dedicated ... and consolidate chemistry-immuno testing with Olympus ... chemistry, specific proteins, esoteric chemistries and ...
This kit has been designed for the quantitative,determination of total immunoreactive intact PTH (Total,Intact PTH) in blood samples. The Total Intact PTH,level is the sum of PTH (1-84) and N-t...
... PoleStar N20, exclusively distributed by Medtronic, ... Combining intra-operative imaging with surgical ... PoleStar N20 is one of the ... , , Exceptional image quality from ...
Microwell IRMA for the detection of Intact PTH...
Medicine Products: